These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 32777751)

  • 1. The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy.
    Ernani V; Appiah AK; Baine MJ; Smith LM; Ganti AK
    Cancer Treat Res Commun; 2020; 24():100197. PubMed ID: 32777751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy.
    Ernani V; Appiah AK; Marr A; Zhang C; Zhen W; Smith LM; Ganti AK
    J Thorac Oncol; 2019 Mar; 14(3):475-481. PubMed ID: 30503890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis.
    Foster CC; Rusthoven CG; Sher DJ; Feldman L; Pasquinelli M; Spiotto MT; Koshy M
    Lung Cancer; 2019 Apr; 130():162-168. PubMed ID: 30885339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients.
    Grinnell M; Appiah AK; Baine M; Ernani V; Marr A; Zhang C; Zhen W; Buddharaju LNR; Smith LM; Ganti AK
    J Geriatr Oncol; 2020 Sep; 11(7):1145-1153. PubMed ID: 32389520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer.
    Baine MJ; Verma V; Schonewolf CA; Lin C; Simone CB
    Lung Cancer; 2018 Apr; 118():20-26. PubMed ID: 29571997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Body Radiation Therapy Versus Nonradiotherapeutic Ablative Procedures (Laser/Cryoablation and Electrocautery) for Early-Stage Non-Small Cell Lung Cancer.
    Baine MJ; Sleightholm R; Neilsen BK; Oupický D; Smith LM; Verma V; Lin C
    J Natl Compr Canc Netw; 2019 May; 17(5):450-458. PubMed ID: 31085762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.
    Iyengar P; Kavanagh BD; Wardak Z; Smith I; Ahn C; Gerber DE; Dowell J; Hughes R; Abdulrahman R; Camidge DR; Gaspar LE; Doebele RC; Bunn PA; Choy H; Timmerman R
    J Clin Oncol; 2014 Dec; 32(34):3824-30. PubMed ID: 25349291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A National Cancer Database Analysis of Radiofrequency Ablation versus Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer.
    Lam A; Yoshida EJ; Bui K; Fernando D; Nelson K; Abi-Jaoudeh N
    J Vasc Interv Radiol; 2018 Sep; 29(9):1211-1217.e1. PubMed ID: 30061058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
    von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
    Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.
    Wu J; Bai HX; Chan L; Su C; Zhang PJ; Yang L; Zhang Z
    J Thorac Cardiovasc Surg; 2020 Nov; 160(5):1350-1357.e11. PubMed ID: 32033815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
    Kann BH; Miccio JA; Stahl JM; Ross R; Verma V; Dosoretz AP; Park HS; Shafman TD; Gross CP; Yu JB; Decker RH
    Radiother Oncol; 2019 Mar; 132():188-196. PubMed ID: 30391106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
    Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
    Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
    Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
    Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma.
    Abel S; Hasan S; White R; Schumacher L; Finley G; Colonias A; Wegner RE
    Lung Cancer; 2019 Feb; 128():127-133. PubMed ID: 30642444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
    Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA
    Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
    Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
    J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
    Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
    Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.
    Raghavan G; Shaverdian N; Chan S; Chu FI; Lee P
    Clin Lung Cancer; 2018 Sep; 19(5):e759-e766. PubMed ID: 29954680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher biologically effective dose is associated with improved survival in patients with squamous cell carcinoma of the lung treated with stereotactic body radiation therapy.
    Parzen JS; Almahariq MF; Quinn TJ; Siddiqui ZA; Thompson AB; Guerrero T; Lee K; Stevens C; Grills IS
    Radiother Oncol; 2021 Jul; 160():25-31. PubMed ID: 33892021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.